Quality and safety review covered the published safety content for GLP1s, the telehealth consent, and the partner page listing the physician network (MD Integrations) and pharmacy partners
C.DiamantM.CornerA.EliassonB.MalloyJ
Common side effects normally go away on their own within a few days or up to 2-3 weeks
Phase 2 trials in obesity and type 2 diabetes have been completed and published in major peer-reviewed medical journals, including data on body weight, glycemic markers, and tolerability
doi: 10.1016/j.diabres.2024.111617, 133 SikiricaM
( H ) Intracellular cAMP accumulation in human caSMCs treated with the sAC inhibitor KH7 (25 M, dark gray bars), the tmAC inhibitor Ddox (50 M, white bars), or PBS (light gray bars) for 3 hours followed by a 15-minute treatment with GLP-1(2836), scrambled control, IPE, or forskolin